Skip to main content

Table 2 Antimicrobial profiling of the compound myricetin

From: Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

Strains

Results

References

Antiviral

 HIV Reverse Transcriptase

0.08 a

[43]

 HIV Reverse Transcriptase, Moloney murine leukemia virus

0.08 b

[53]

Antimicrobial

Gram positive

Actinomyces viscosus

20 b

[54]

Burkholderia cepacia

>512 b

[55]

Corynebacterium diphtheriticum

18.2 e

[56]

Enterococcus faecalis

17.0 e

[56]

Enterococcus faecalis 2400

17.0 e

[56]

Enterococcus faecium

16.8 e

[56]

  Methicillin-resistant Staphylococcus aureus

256 b

[55]

Staphylococcus aureus ATCC6538p

> 300 c

[57]

Staphylococcus aureus

> 2000 b

[58]

Staphylococcus epidermidis ATCC14490

64 b

[55]

Staphylococcus epidermidis

> 2000 b

[58]

Staphylococcus epidermidis

17.4 e

[56]

Staphylococcus saprophyticus

17.6 e

[56]

Streptococcus mutans

20 b

[54]

Streptococcus pneumoniae 49

128 b

[55]

Streptococcus pneumoniae

17.4 e

[56]

Streptococcus pyogenes

16.4 e

[56]

  Vancomycin-Resistant Enterococci (VRE)

512

[55]

Gram negative

Burkholderia cepacia

64 b

[55]

Enterobacter aerogenes

256 b

[55]

Escherichia coli

> 2000 b

[58]

Escherichia coli WT

12.2 e

[56]

Escherichia coli BU40

12.6 e

[56]

Escherichia coli FPL5014

11.6 e

[56]

Escherichia coli DnaB helicase

11.3 d

[42]

Klebsiella pneumoniae ATCC13883

64 b

[55]

Klebsiella pneumoniae

128 b

[59]

Klebsiella pneumoniae

> 2000 b

[58]

Klebsiella pneumoniae

16.6 e

[56]

Porphyromonas gingivalis

2500 b

[54]

Prevotella intermedia

1250 b

[54]

Proteus mirabilis

16.5 e

[56]

Pseudomonas aeruginosa ATCC27853

256 b

[55]

Pseudomonas aeruginosa

> 2000 b

[58]

Pseudomonas aeruginosa PAO286

15.6 e

[56]

Salmonella paratyphi A

14.4 e

[56]

Salmonella paratyphi B

14.4 e

[56]

Salmonella typhi

14.4 e

[56]

Shigella dysenteriae

15.5 e

[56]

Shigella flexneri

13.4 e

[56]

Shigella sonnei

14.6 e

[56]

Anti-chlamydial

Chlamydia pneumoniae

29 c

[60]

  1. Microbial strain is inserted when microbial type is repeated and information available
  2. aKi (μM)
  3. bminimum inhibitory concentration (MIC, μg/mL)
  4. cMIC (μM)
  5. dhalf maximal inhibitory concentration (IC50, μM)
  6. ezone of inhibition (ZOI, mm) for 100 μL of 0.5 mg/mL myricetin